Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Progyny (Nasdaq: PGNY) announced that CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 3:30 p.m. ET. Live audiocasts and replays will be accessible via the Events and Presentations section of Progyny’s investor relations website.
Details
News Market Reaction – PGNY
On Aug 7, the day this news came out, PGNY closed 6.98% below the previous close. Argus tracked a peak move of +4.5% during that session. Argus tracked a trough of -2.2% from its starting point during tracking. Our momentum scanner recorded 11 alerts for this stock that day. That session’s volume was 3.1x the stock’s average daily volume.
Data tracked by StockTitan Argus for the Aug 7 session.
Key Figures
- Conference date
- August 11, 2026
- Canaccord Genuity 46th Annual Growth Conference
- Presentation time
- 3:30 p.m. ET
- Canaccord Genuity Annual Growth Conference
- Conference edition
- 46th
- Canaccord Genuity Annual Growth Conference
Historical Context
-
Announced timing and conference-call details for second-quarter 2026 results
-
Survey showed demand for personalized guidance across fertility and women’s health
-
Board authorized up to $200 million of common-stock buybacks
-
Announced CEO and CFO participation in a healthcare conference fireside chat
-
Reported record first-quarter revenue, profit and adjusted EBITDA
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 3:30 p.m. ET.
Live audiocasts and replays of the webcasted session will be available in the Events and Presentations section of Progyny’s investor relations website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.